CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Talis Biomedical Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Talis Biomedical Corp
1375 West Fulton Market, Suite 700
Phone: (650) 433-3000p:650 433-3000 CHICAGO, IL  60607  United States Ticker: TLISTLIS
This company ceased filing statements with the SEC on 9/30/2024.
Business Summary
Talis Biomedical Corporation is a molecular diagnostic company. The Company is focused on advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care.
(Source: PROSPECTUS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202412/31/2023YesYes--Yes

Industries
SIC Code Description
3826 Laboratory analytical instruments
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Director RobertKelley 52 12/1/2021 9/1/2020
Co-Founder, Director Rustem F.Ismagilov 50 6/1/2013 6/1/2013
Interim Chief Financial Officer RebeccaMarkovich 51 4/21/2023 4/21/2023
5 additional Officers and Directors records available in full report.

General Information
Number of Employees: 99 (As of 12/31/2023)
Outstanding Shares: 1,822,153 (As of 6/30/2024)
Shareholders: 69
Stock Exchange: OTC
Federal Tax Id: 463122255
Fax Number: (302) 636-5454


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, December 2, 2024